Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, has promoted Konstantin Petropoulos, PhD, MBA, to Chief Executive Officer.   Petropoulos has served as the Company’s Chief Business Officer since June 2023. Meanwhile, Alexander Gebauer, MD, PhD, is stepping down with immediate effect to focus his efforts on another company, Galimedix Therapeutics, that he has co-founded and is leading. He will continue t...